Clinical and laboratory polymorphism of mitochondrial diseases by the example of A3243G mutation in mitochondrial DNA
https://doi.org/10.30629/2658-7947-2022-27-3-28-34
Abstract
The article is devoted to the clinical polymorphism of mitochondrial diseases by the example of A3243G mutation in mitochondrial DNA. The article also discusses clinical criteria and an algorithm for the diagnosis of mitochondrial diseases.
Material and methods. Тhree families with A3243G mutation in mitochondrial DNA are presented. All patients underwent clinical neurological examination, instrumental examination (ECG, Echo-CG, MRI and CT of the brain, EEG, needle and stimulation electromyography, audiometry), biochemical study of the level of lactic and pyruvic acids in the blood before and after exercise, muscle biopsy.
Results. Аll patients had myopathy, exercise intolerance, sensorineural hearing loss, short stature; other symptoms varied. According to the results of muscle biopsy, the phenomenon of «ragged red fibers» was found in two patients. The diagnosis was confirmed by molecular genetic examination.
Conclusion. Мitochondrial diseases with the same mutation are characterized by significant variability of clinical symptoms. The identification of clinician traits characteristic of a group of mitochondrial diseases should alert the doctors to this pathology.
About the Authors
Yu. V. Mozolevsky
The First Moscow Scientific and Practical Center for Medical Rehabilitation, Rehabilitation and Sports Medicine (MNPC MRVSM DZM)
Russian Federation
Russian Federation
Moscow
L. T. Akhmedzhanova
Institute of Clinical Medicine. N.V. Sklifosovsky Research Institute for Emergency Medicine, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
T. S. Titova
Institute of Clinical Medicine. N.V. Sklifosovsky Research Institute for Emergency Medicine, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
O. A. Solokha
Institute of Clinical Medicine. N.V. Sklifosovsky Research Institute for Emergency Medicine, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
T. A. Yanakaeva
Institute of Clinical Medicine. N.V. Sklifosovsky Research Institute for Emergency Medicine, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
E. V. Mandra
Institute of Clinical Medicine. N.V. Sklifosovsky Research Institute for Emergency Medicine, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
References
1. Craven L., Alston C.L., Taylor R.W., Turnbull D.M. Recent Advances in Mitochondrial Disease. Annual Review of Genomics and Human Genetics. 2017;18(1):257–275. https://doi.org/10.1146/annurev-genom-091416-035426
2. Murayama K., Shimura M., Liu Z., Kazaki Y, Ohtake A. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases. J Hum Genet. 2019; 64:113–125. https://doi.org/10.1038/s10038-018-0528-6
3. Thorburn D.R. Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis. 2004;27:349–362. https://doi.org/10.1023/B:BOLI.0000031098.41409.55
4. El-Hattab A.W., Adesina A.M., Jones J., Scaglia F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Molecular Genetics and Metabolism. 2015;116(1–2):4–12. https://doi.org/10.1016/j.ymgme.2015.06.004
5. Davison J.E., Rahman S. Recognition, investigation and management of mitochondrial disease. Archives of Disease in Childhood. 2017;102:1082–1090. https://doi.org/10.1136/archdischild-2016-311370
6. Мазунин И.О., Володько Н.Б., Стариковская Е.Б. Митохондриальный геном и митохондриальные заболевания человека. Молекулярная биология. 2010;44(5):755–772. [Mazunin I.O., Volodko N.B., Starikovskaya E.B. The mitochondrial genome and human mitochondrial diseases. Journal of Molecular Biology. 2010;44(5):755–772. (In Russ.)]. https://pubmed.ncbi.nlm.nih.gov/21090233
7. Finsterer J. Mitochondriopathies. Eur. J. Neurol. 2004;V(11):163– 186. https://doi.org/10.1046/j.1351-5101.2003.00728.x
8. Parikh S., Goldstein A., Koenig M.K., Scaglia F., Enns G.M., Saneto R. et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17:689–701. https://doi.org/10.1038/gim.2014.177
9. Deschauer M., Müller T., Wieser T., Schulte-Mattler W., Kornhuber M., Zierz S. Hearing impairment is common in various phenotypes of the mitochondrial DNA A3243G mutation. Arch Neurol. 2001;58:1885–1888. https://doi.org/10.1001/archneur.58.11.1885
10. Sproule D.M., Kaufmann P., Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann. N. Y. Acad. Sci. 2008;1142:133–158. https://doi.org/10.1196/annals.1444.011.
11. Муранова А.В., Строков И.А. Митохондриальные цитопатии: синдромы MELAS и MIDD. Один генетический дефект — разные клинические фенотипы. Неврологический журнал. 2017;22(1):19–24. [Muranova A.V., Strokov I.A. Mitochondrial cytopathies: MELAS and MIDD syndromes. One genetic defect — different clinical phenotypes. Neurological Journal. 2017;22(1):19–24. (In Russ.)]. https://doi.org/10.18821/1560-9545-2017-22-1-19-24
12. Lax N.Z., Hepplewhite P.D., Reeve A.K., Nesbitt V., McFarland R., Jaros E. et al. Cerebellar Ataxia in Patients with Mitochondrial DNA Disease: A Molecular Clinicopathological Study. J Neuropathol Exp Neurol. 2012;71(2):148–161. https://doi.org/10.1097/NEN.0b013e318244477d
13. Nesbitt V., Pitceathly R.D., Turnbull D.M., Taylor R.W., Sweeney M.G., Mudanohwo E.E. et al. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation—implications for diagnosis and management. Journal of Neurology, Neurosurgery & Psychiatry. 2013;84:936–938. https://doi.org/10.1136/jnnp-2012-303528
14. Malhotra K., Liebeskind D.S. Imaging of MELAS. Curr Pain Headache Rep. 2016;20(9):54. https://doi.org/10.1007/s11916-016-0583-7
15. Иллариошкин С.Н. Алгоритм диагностики митохондриальных энцефаломиопатий. Нервные болезни. 2007;7:23–27. [Illarioshkin S.N. Algorithm for the diagnosis of mitochondrial encephalomyopathies. Nervous diseases. 2007;7:23–27. (In Russ.)]. https://cyberleninka.ru/article/n/algoritm-diagnostiki-mitohondrialnyh-entsefalomiopatiy/viewer
Review
For citations:
Mozolevsky Yu.V., Akhmedzhanova L.T., Titova T.S., Solokha O.A., Yanakaeva T.A., Mandra E.V. Clinical and laboratory polymorphism of mitochondrial diseases by the example of A3243G mutation in mitochondrial DNA. Russian neurological journal. 2022;27(3):28-34. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-3-28-34
Views:
454
Email this article 